SPDR S&P Biotech ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
XBI price
Table
| Date | XBI close |
|---|---|
| Oct 16, 2026 | $144.32 |
| Oct 19, 2026 | $147.86 |
| Oct 20, 2026 | $153.24 |
| Oct 21, 2026 | $152.78 |
| Oct 22, 2026 | $151.64 |
| Oct 23, 2026 | $149.54 |
| Oct 26, 2026 | $150.47 |
| Oct 27, 2026 | $154.84 |
| Oct 28, 2026 | $157.51 |
| Oct 29, 2026 | $157.79 |
| Oct 30, 2026 | $155.98 |
| Nov 2, 2026 | $152.05 |
| Nov 3, 2026 | $154.97 |
| Nov 4, 2026 | $159.10 |
| Nov 5, 2026 | $148.40 |
| Nov 6, 2026 | $152.21 |
| Nov 9, 2026 | $156.90 |
| Nov 10, 2026 | $155.06 |
| Nov 11, 2026 | $156.31 |
| Nov 12, 2026 | $151.20 |
| Nov 13, 2026 | $150.55 |
| Nov 16, 2026 | $145.88 |
Daily net flows, 1M
Net inflow over the range: +$108M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct 13 | $96.7M |
| Oct 14 | $18.3M |
| Oct 15 | $67M |
| Oct 16 | −$66.2M |
| Oct 19 | −$264.4M |
| Oct 20 | $177.1M |
| Oct 21 | $272.7M |
| Oct 22 | −$38M |
| Oct 23 | −$44.9M |
| Oct 26 | −$222.1M |
| Oct 27 | −$148.5M |
| Oct 28 | $302.8M |
| Oct 29 | −$86.9M |
| Oct 30 | $285.9M |
| Nov 2 | −$138.9M |
| Nov 3 | −$146.7M |
| Nov 4 | $35.4M |
| Nov 5 | −$133.8M |
| Nov 6 | $30.1M |
| Nov 9 | −$89M |
| Nov 10 | $97.1M |
| Nov 11 | $3.9M |
| Nov 12 | $171.7M |
| Nov 13 | −$71.4M |
Money is leaving — −$8M in net outflows over the past month, while the price has returned +19.6% so far this year. At 0.35% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 2.47% | $215.27 | -3.6% | ||
| 2 | BIIBBIOGEN | 1.80% | $251.65 | -0.7% | ||
| 3 | AMGNAMGEN | 1.79% | $462.32 | -0.7% | ||
| 4 | REGNREGENERON PHARMACEUTICALS | 1.78% | $952.40 | -0.3% | ||
| 5 | ABBVABBVIE | 1.76% | $294.55 | -0.2% | ||
| 6 | UTHRUNITED THERAPEUTICS | 1.75% | $587.88 | -0.6% | ||
| 7 | GILDGILEAD SCIENCES | 1.74% | $167.58 | -0.3% | ||
| 8 | EXELEXELIXIS | 1.78% | $67.10 | -2.8% | ||
| 9 | TGTXTG THERAPEUTICS | 1.77% | $62.76 | -2.7% | ||
| 10 | SYRESPYRE THERAPEUTICS INC | 1.80% | $99.37 | -4.5% | ||
| 11 | ORKAOruka Therapeutics | 1.73% | $99.24 | -5.8% | ||
| 12 | NBIXNEUROCRINE BIOSCIENCES | 1.62% | $165.31 | -1.2% | ||
| 13 | VRTXVERTEX PHARMACEUTICALS | 1.55% | $537.79 | -0.2% | ||
| 14 | ALKSALKERMES | 1.56% | $46.53 | -1.1% | ||
| 15 | BBIOBRIDGEBIO PHARMA | 1.55% | $77.36 | -1.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 165Sector weights
- Healthcare99.46%
- Health Technology99.1%
- Health Services0.86%
- Financial Services0.54%
- Other0.07%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 99.46% |
| Health Technology | 99.1% |
| Health Services | 0.86% |
| Financial Services | 0.54% |
| Other | 0.07% |
Country weights
- United States96.69%
- United Kingdom1.41%
- Switzerland1.33%
- Netherlands0.45%
- Bermuda0.34%
- Ireland0.08%
Show as table
| Item | Value (%) |
|---|---|
| United States | 96.69% |
| United Kingdom | 1.41% |
| Switzerland | 1.33% |
| Netherlands | 0.45% |
| Bermuda | 0.34% |
| Ireland | 0.08% |
| 1 week | -5.9% |
| 1 month | +1.1% |
| 3 months | -7.3% |
| 6 months | +11.6% |
| YTD | +19.6% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$201M |
| 1 month | −$8M |
| 3 months | +$160M |
| YTD | +$727M |
| 1 year | +$675M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Dec | −$387.7M |
| Jan | $286.1M |
| Feb | −$441.2M |
| Mar | −$590.6M |
| Apr | $627.7M |
| May | −$231.2M |
| Jun | $922M |
| Jul | −$366.3M |
| Aug | $765.8M |
| Sep | −$689.2M |
| Oct | $685.4M |
| Nov | −$241.6M |
The top holding is 2.5% of the book; the top ten carry 18%. Spread across 160+ names, it behaves like roughly 88 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $30M | $26M |
| SLS SELLAS LIFE SCIENCES GROUP | $10M | $13M |
| NTRA NATERA | $20M | $1M |
| SMMT SUMMIT THERAPEUTICS | $5M | $5M |
| CGON CG ONCOLOGY INC | $3M | $6M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat XBI on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -32bp on fee · 4× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -32bp on fee · 2× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -30bp on fee · 12× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -31bp on fee · 3× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -31bp on fee · 2× the assets · +$422M in over the month | Head-to-head |